USD 12.82
(0.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 2.31 Million | 5.92 Million | 4.66 Million | 4.41 Million | 2.86 Million | 3.82 Million |
Net Income | 2.71 Million | 3.58 Million | 4.59 Million | 4.26 Million | 2.63 Million | 1.58 Million |
Depreciation & Amortization | 804.69 Thousand | 886.76 Thousand | 922.51 Thousand | 747.06 Thousand | 730.55 Thousand | 631.21 Thousand |
Deferred income taxes | -98.65 Thousand | -168.67 Thousand | 338.44 Thousand | -297.49 Thousand | -135.05 Thousand | 14.34 Thousand |
Stock-based compensation | - | 401.97 Thousand | 315.94 Thousand | 267.31 Thousand | 326.27 Thousand | 388.68 Thousand |
Change in working capital | -489.06 Thousand | 123.1 Thousand | -656.27 Thousand | 553.4 Thousand | -222.4 Thousand | 340.17 Thousand |
Other non-cash items | -612.49 Thousand | 1.09 Million | -850.57 Thousand | -1.11 Million | -466.16 Thousand | 872.87 Thousand |
Investing Cash Flow | -19.87 Million | -30.43 Million | -52.32 Million | -12.98 Million | -52.73 Million | -47.12 Million |
Investments in PPE | -200.6 Thousand | -323.56 Thousand | -2.41 Million | -1.19 Million | -1.18 Million | -850.89 Thousand |
Acquisitions | - | -30.82 Million | -38.97 Million | -6.82 Million | -40.95 Million | -36.4 Million |
Investment purchases | -14.84 Million | -249 Thousand | -20.26 Million | -13.6 Million | -23.63 Million | -10.11 Million |
Sales/Maturities of investments | 21.87 Million | 1.35 Million | 8.71 Million | 9.27 Million | 15.25 Million | 2.49 Million |
Other Investing Activities | -26.7 Million | -391.45 Thousand | 627.35 Thousand | -639.57 Thousand | -2.2 Million | -2.24 Million |
Financing Cash Flow | 26.2 Million | 21.85 Million | 28.98 Million | 22.95 Million | 60.65 Million | 43.09 Million |
Debt repayment | -10.29 Million | -6 Million | -5 Million | -13 Million | -27.07 Million | -31.95 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | -497.58 Thousand | -1.51 Million | -1.06 Million | -1.6 Million | -3 Million | -1.32 Million |
Common Stock Issuance | - | - | - | - | 12.43 Thousand | - |
Other Financing Activities | 36.99 Million | 29.36 Million | 35.05 Million | 37.56 Million | 90.73 Million | 76.38 Million |
Accounts receivables | - | -728.13 Thousand | -187.21 Thousand | 350.83 Thousand | -353.17 Thousand | -537.93 Thousand |
Accounts payables | - | 445.21 Thousand | -569.91 Thousand | 830.33 Thousand | 236.9 Thousand | 903.3 Thousand |
Inventory | - | - | - | - | - | - |
Other working capital | -489.06 Thousand | 406.01 Thousand | 100.85 Thousand | -627.75 Thousand | -106.13 Thousand | -25.19 Thousand |
Cash at beginning of period | - | 11.06 Million | 29.73 Million | 15.34 Million | 4.55 Million | 4.75 Million |
Cash at end of period | 8.64 Million | 8.4 Million | 11.06 Million | 29.73 Million | 15.34 Million | 4.55 Million |
Capital Expenditure | -200.6 Thousand | -323.56 Thousand | -2.41 Million | -1.19 Million | -1.18 Million | -850.89 Thousand |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 8.64 Million | -2.65 Million | -18.67 Million | 14.38 Million | 10.78 Million | -194.67 Thousand |
Free Cash Flow | 2.11 Million | 5.6 Million | 2.24 Million | 3.22 Million | 1.67 Million | 2.97 Million |
Breakdown | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 | 2022 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 625.93 Thousand | 571.23 Thousand | 667.35 Thousand | 3.58 Million | 905.09 Thousand | 975.76 Thousand |
Depreciation & Amortization | - | - | - | 886.76 Thousand | - | - |
Deferred income taxes | - | - | - | -168.67 Thousand | - | - |
Stock-based compensation | - | - | - | 401.97 Thousand | - | - |
Change in working capital | - | - | - | 123.1 Thousand | - | - |
Other non-cash items | -625.93 Thousand | -571.23 Thousand | -667.35 Thousand | 1.09 Million | -905.09 Thousand | -975.76 Thousand |
Investing Cash Flow | - | - | - | -30.43 Million | - | - |
Investments in PPE | - | - | - | -323.56 Thousand | - | - |
Acquisitions | - | - | - | -30.82 Million | - | - |
Investment purchases | - | - | - | -249 Thousand | - | - |
Sales/Maturities of investments | - | - | - | 1.35 Million | - | - |
Other Investing Activities | - | - | - | -391.45 Thousand | - | - |
Financing Cash Flow | - | - | - | 21.85 Million | - | - |
Debt repayment | - | - | - | -6 Million | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | -1.51 Million | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | 29.36 Million | - | - |
Accounts receivables | - | - | - | -728.13 Thousand | - | - |
Accounts payables | - | - | - | 445.21 Thousand | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | 406.01 Thousand | - | - |
Cash at beginning of period | - | - | - | 11.06 Million | - | - |
Cash at end of period | - | - | - | 8.4 Million | - | - |
Capital Expenditure | - | - | - | -323.56 Thousand | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | -2.65 Million | - | - |
Free Cash Flow | - | - | - | 5.6 Million | - | - |
KPIL
TKO
AUI
MITUF
JBCHEPHARM
RFG